Waldiers ring

Reading File

Searching the Web

Waldeyer's ring anatomy lymphoid tissue pharynx

Finding Sources

Reading File

Here is a thorough overview of Waldeyer's Ring based on authoritative otolaryngology and radiology textbooks.

Waldeyer's Ring

Waldeyer's ring is a circumpharyngeal ring of mucosa-associated lymphoid tissue (MALT) located at the entry point to the aerodigestive tract - specifically in the nasopharynx and oropharynx. It acts as the body's first immunological checkpoint for both inhaled air and ingested food.

Components

The ring has both discrete tonsillar aggregates and scattered lymphoid tissue throughout the pharyngeal mucosa:

Component	Location	Epithelium
Pharyngeal tonsil (Adenoids)	Posterior midline roof of nasopharynx	Respiratory (ciliated columnar)
Tubal (Gerlach) tonsils	Within the lip of the fossa of Rosenmuller, posterior to the torus tubarius (eustachian tube opening)	Respiratory
Palatine tonsils	Between the palatoglossal and palatopharyngeal arches in the lateral oropharynx	Stratified non-keratinized squamous
Lingual tonsils	Posterior one-third of the tongue	Stratified non-keratinized squamous
Lateral pharyngeal bands	Lymphoid tissue behind the posterior pillars	-

Note: The tubal tonsils are not always present. In addition to these discrete aggregates, scattered collections of lymphoid tissue sit in the lamina propria beneath the epithelium and at the intertonsillar intervals; on the posterior pharyngeal wall they appear as small, slightly raised salmon-pink swellings.

Inner and Outer Ring

Waldeyer's ring has two functional rings:

Inner ring: The tonsils themselves (pharyngeal, tubal, palatine, lingual)
Outer ring: The regional draining lymph nodes (deep cervical, retropharyngeal, jugulodigastric nodes)

Immunological Function

B lymphocytes proliferate in germinal centers within tonsillar tissue
Immunoglobulins (IgG, IgA, IgM, IgD), complement components, interferons, lysozymes, and cytokines accumulate here
Acts as an antigen-sampling center for the upper aerodigestive tract:
- Adenoids and tubal tonsils trap antigens from inspired air
- Palatine and lingual tonsils sample antigens from ingested food
The adenoid mucosa is folded into furrows to increase surface area for antigen trapping; the palatine tonsils have 10-20 crypts that similarly increase mucosal surface area
The tonsils are considered the first line of defense of the immune system, particularly in children

Palatine Tonsils - Key Details

(From Scott-Brown's Otorhinolaryngology Head & Neck Surgery)

Size: Maximal during puberty; involute thereafter with little lymphoid tissue in old age
Blood supply: Predominantly the tonsillar branch of the facial artery (a branch of the external carotid artery)
Venous drainage: Paratonsillar vein -> external palatine vein
Lymphatics: Drain to the jugulodigastric node (deep cervical chain)
Innervation: Branches of the glossopharyngeal nerve - this explains why tonsillar pathology can cause referred otalgia
Intratonsillar cleft (recessus palatinus): A notable structural feature within the substance of the tonsil

Clinical Correlations

Referred otalgia: An offshoot of the glossopharyngeal nerve (the tympanic nerve) supplies the tympanic cavity. Any pathology in the tonsillar fossa can present as ear pain.

Lymphoma: Waldeyer's ring is the commonest site of head and neck lymphoma. The tonsils are most frequently affected, typically showing asymmetrical thickening of the pharyngeal mucosa on CT/MRI. Up to 20% are MALT-type, with a known link to GI tract involvement (synchronous or metachronous). On imaging, NHL is suggested by circumferential or multifocal involvement, intensely FDG-avid on PET/CT.

Adenotonsillar hypertrophy: Because of their immune role in childhood, adenoids and tonsils enlarge most rapidly between ages 5-6, reaching peak size at puberty, then involuting.

Sources: K.J. Lee's Essential Otolaryngology; Scott-Brown's Otorhinolaryngology Head & Neck Surgery; Grainger & Allison's Diagnostic Radiology

Give me viva question for breast

Asking for Preferences

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Here is a comprehensive set of MBBS-level viva questions on the breast, covering anatomy, pathology, and surgery, with model answers drawn from authoritative textbooks.

Viva Questions: Breast (MBBS Level)

ANATOMY

Q1. What are the boundaries of the breast? The breast lies between the skin and the superficial pectoral fascia, overlying the pectoralis major muscle. It extends from the 2nd to 6th rib vertically, and from the lateral border of sternum to the mid-axillary line horizontally. The axillary tail of Spence extends into the axilla through an opening in the deep fascia (foramen of Langer).

Q2. What are Cooper's ligaments? What is their clinical significance? Cooper's suspensory ligaments are fibrous bands running from the chest wall and deep fascia to the dermis, giving shape and support to the breast. When cancer infiltrates these ligaments, they contract and tether the skin, producing dimpling of the skin surface. Pitting edema of breast lymphatics gives the classic "peau d'orange" (orange-skin) appearance.

Sabiston Textbook of Surgery, p. 1369

Q3. What are the three principal tissue types of the mature breast?

Glandular epithelium
Fibrous stroma
Adipose tissue The breast also contains lymphocytes and macrophages. Post-menopausally, glandular structures involute and are largely replaced by adipose tissue.

Q4. What is the TDLU? Why is it important? The Terminal Duct Lobular Unit (TDLU) is composed of acini (milk-forming glands) and their small ductules. It is the functional unit of the breast and is also the site of origin of most breast carcinomas (both ductal and lobular carcinoma arise from the TDLU).

Q5. How many lobes does the breast have? How do they drain? There are 15-20 lobes, each ending in a lactiferous duct that opens at the nipple. Each major duct has a dilated lactiferous sinus just beneath the nipple-areolar complex (NAC) before opening.

Q6. Describe the lymphatic drainage of the breast. Lymph from the nipple, areola, and lobules first drains to the subareolar lymphatic plexus, then:

~75% drains to axillary lymph nodes - initially to the external mammary (anterior/pectoral) nodes
Also drains to interpectoral, deltopectoral, supraclavicular, and parasternal (internal mammary) nodes
Minor drainage to the opposite breast and abdominal nodes (inferior phrenic)

Axillary nodes are divided into 3 levels:

Level I - lateral/inferior to pectoralis minor (low axilla)
Level II - behind pectoralis minor (mid-axilla)
Level III - medial/superior to pectoralis minor (apex of axilla)
Fischer's Mastery of Surgery, p. 1396

Q7. What is the blood supply of the breast?

Branches of the axillary artery: thoracoacromial, lateral thoracic
Internal thoracic (mammary) artery: 2nd, 3rd, 4th perforating branches (2nd perforating is usually the largest)
Posterior intercostal arteries: 2nd, 3rd, 4th

Q8. What is the intratonsillar cleft (recessus palatinus) equivalent in the breast? The intratonsillar cleft (recessus palatinus) is a term from tonsil anatomy. The equivalent structural landmark in the breast is the lactiferous sinus (the dilated segment of the lactiferous duct just beneath the nipple), which is the collecting reservoir during breastfeeding.

PATHOLOGY

Q9. What are the types of benign breast disease? What is the most common benign tumor of the breast? Fibroadenoma is the most common benign breast tumor. It arises from the intralobular stroma and is a biphasic tumor (epithelial + stromal). It typically presents in young women (15-35 years) as a well-defined, mobile, rubbery, non-tender lump ("breast mouse"). Fibroadenomas do not increase the risk of breast cancer. If core biopsy-confirmed and ≤3 cm, clinical observation is appropriate.

Robbins Pathology; Fischer's Mastery of Surgery

Q10. What are the types of breast carcinoma? Which is the most common? Using the Foote & Stewart classification:

Invasive ductal carcinoma (IDC/NST) - 80% - most common
Invasive lobular carcinoma - 10%
Medullary carcinoma - 4%
Mucinous (colloid) carcinoma - 2%
Papillary carcinoma - 2%
Tubular carcinoma - 2%
Paget's disease of the nipple
Rare types (adenoid cystic, squamous cell, apocrine)

To qualify as a "special type," ≥90% of the tumor must show the defining histologic features. About 80% of invasive cancers are NST (no special type), with worse prognosis.

Schwartz's Principles of Surgery, 11th ed.

Q11. What is DCIS? How does it appear on mammography? Ductal Carcinoma In Situ (DCIS) is non-invasive carcinoma confined within the ducts (basement membrane intact). On mammography it classically appears as clustered microcalcifications, sometimes with a poorly defined mass. Histologically it may show necrosis (comedo type). Treatment is lumpectomy ± radiation or mastectomy depending on extent.

Q12. What is Paget's disease of the nipple? Described by James Paget in 1874, it presents as a chronic eczematous eruption of the nipple that may progress to an ulcerated, weeping lesion. It is almost always associated with underlying DCIS and sometimes invasive carcinoma.

Pathognomonic finding: Large, pale, vacuolated Paget cells in the rete pegs of the nipple epithelium
Differentiating from melanoma: CEA immunostaining (+) in Paget's disease; S-100 antigen (+) in melanoma
Schwartz's Principles of Surgery

Q13. What is peau d'orange? What causes it? Peau d'orange is a cutaneous sign of breast cancer where the skin has the texture of an orange peel - dimpled, thickened, and edematous. It is caused by obstruction of dermal lymphatics, causing edema, combined with tethering of the skin by Cooper's ligaments. It is the hallmark of inflammatory breast cancer (IBC), but also seen in locally advanced breast cancer.

Q14. What are the risk factors for breast cancer?

Female sex, increasing age
Family history (first-degree relative), BRCA1/BRCA2 mutations
Early menarche, late menopause (prolonged estrogen exposure)
Nulliparity or late first pregnancy (>30 years)
Exogenous hormone use (OCP, HRT)
Prior breast cancer or atypical hyperplasia on biopsy
Dense breast tissue on mammography
Radiation exposure to chest

SURGERY / CLINICAL

Q15. What are the signs and symptoms of breast cancer?

Hard, irregular, non-tender, poorly mobile lump
Skin dimpling or retraction
Nipple retraction or discharge (blood-stained)
Peau d'orange
Axillary lymphadenopathy
In advanced cases: ulceration, arm edema, bone pain, jaundice (metastases)

Q16. What is a sentinel lymph node biopsy (SLNB)? When is it used? SLNB is the removal and examination of the first lymph node(s) to receive drainage from the tumor - i.e., the node most likely to harbor metastasis if nodal spread has occurred. It uses a blue dye and/or radioisotope (Tc-99m sulfur colloid). SLNB has replaced routine axillary lymph node dissection (ALND) for clinically node-negative breast cancer, significantly reducing morbidity (lymphedema). SLNB is contraindicated in inflammatory breast cancer (IBC) because of diffuse lymphatic involvement.

Current Surgical Therapy, 14th ed.

Q17. What are the surgical options for breast cancer?

Procedure	Description
Breast-conserving surgery (BCS/lumpectomy)	Wide local excision + sentinel node biopsy + postoperative radiation
Simple (total) mastectomy	Removal of breast tissue + NAC only
Modified radical mastectomy (MRM)	Removal of breast + axillary node dissection; pectoralis major preserved
Radical mastectomy (Halsted)	Breast + both pectoral muscles + axillary nodes - now rarely done

For DCIS, BCS or simple mastectomy is appropriate depending on extent.

Q18. What is inflammatory breast cancer (IBC)? How is it managed? IBC is an aggressive form of locally advanced breast cancer where tumor emboli obstruct dermal lymphatics. It presents with rapid breast enlargement, warmth, erythema, and peau d'orange - often without a discrete palpable mass. Biopsy shows dermal lymphatic invasion. Treatment:

Neoadjuvant chemotherapy (primary treatment)
Modified radical mastectomy (BCS is absolutely contraindicated)
Post-mastectomy radiation

Q19. What is Triple Assessment in breast disease? Triple assessment is the gold standard approach for evaluating a breast lump:

Clinical examination - history + physical exam
Imaging - mammography (women >35) and/or ultrasound (women <35)
Pathology - core needle biopsy or fine needle aspiration cytology (FNAC)

All three components must agree ("concordant triple assessment") before a diagnosis is accepted.

Q20. What are the molecular/receptor subtypes of breast cancer? Based on receptor status:

Luminal A: ER+/PR+, HER2-, low Ki-67 - best prognosis
Luminal B: ER+/PR+, HER2+ or high Ki-67 - intermediate prognosis
HER2-enriched: ER-, PR-, HER2+ - treated with trastuzumab (Herceptin)
Triple-negative (TNBC): ER-, PR-, HER2- - worst prognosis, no targeted therapy available; often BRCA1-associated

Sources: Sabiston Textbook of Surgery; Schwartz's Principles of Surgery (11th ed.); Fischer's Mastery of Surgery (8th ed.); Mulholland & Greenfield's Surgery; Robbins Pathologic Basis of Disease; Current Surgical Therapy (14th ed.)

This is a shared conversation. Sign in to Orris to start your own chat.